Humankind Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.92M Buy
+211,000
New +$5.62M 3.38% 13
2025
Q4
Sell
-94,931
Closed -$2.42M 123
2025
Q3
$2.42M Sell
94,931
-5,340
-5% -$132K 0.55% 26
2025
Q2
$2.43M Buy
100,271
+4,892
+5% +$114K 0.59% 25
2025
Q1
$2.42M Sell
95,379
-3,593
-4% -$94K 0.63% 24
2024
Q4
$2.63M Buy
98,972
+15,319
+18% +$416K 0.66% 23
2024
Q3
$2.42M Buy
83,653
+5,709
+7% +$167K 0.87% 19
2024
Q2
$2.18M Sell
77,944
-22,153
-22% -$610K 0.58% 27
2024
Q1
$2.78M Buy
100,097
+25,812
+35% +$716K 0.73% 23
2023
Q4
$2.14M Buy
74,285
+13,406
+22% +$405K 0.63% 27
2023
Q3
$2.02M Sell
60,879
-598
-1% -$21.1K 0.84% 20
2023
Q2
$2.25M Buy
61,477
+2,279
+4% +$88.7K 0.88% 18
2023
Q1
$2.42M Buy
59,198
+6,290
+12% +$272K 1% 14
2022
Q4
$2.71M Buy
52,908
+2,009
+4% +$96.3K 1.18% 12
2022
Q3
$2.23M Buy
50,899
+10,720
+27% +$521K 1.07% 15
2022
Q2
$2.11M Sell
40,179
-1,680
-4% -$85.6K 1.01% 14
2022
Q1
$2.17M Buy
41,859
+3,640
+10% +$189K 0.89% 16
2021
Q4
$2.26M Buy
38,219
+2,216
+6% +$110K 2.84% 5
2021
Q3
$1.55M Sell
36,003
-6,334
-15% -$281K 2.36% 9
2021
Q2
$1.66M Buy
42,337
+15,300
+57% +$595K 2.95% 6
2021
Q1
$980K Buy
+27,037
New +$960K 3.01% 7

Other funds holding PFE

Humankind Investments's PFE Position: Q1 2026 in Review

Humankind Investments opened a new position in Pfizer (PFE) in Q1 2026: 211,000 shares worth $5.92M. The stake represents 3.38% of the portfolio and ranks #13 among its holdings. This is a return to the name: Humankind Investments previously reported a position in PFE as recently as Q3 2025.

Humankind Investments first reported a position in PFE in Q1 2021 and has held it in 20 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Humankind Investments held 211,000 shares of Pfizer worth $5.92M as of Q1 2026.
  • Pfizer was a new Humankind Investments position in Q1 2026.
  • Pfizer made up 3.38% of Humankind Investments's portfolio in Q1 2026, its #13 holding.
  • Humankind Investments first reported a position in Pfizer in Q1 2021 and has held it in 20 quarters since.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Humankind Investments's 13F filing for Q1 2026, filed 15 May 2026.